FDA accepts BLA for INO-3107, a DNA immunotherapy for HPV-6 and HPV-11-associated recurrent respiratory papillomatosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback